Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.779822
Title: The role of mevalonate derived metabolites (isoprenoids) in statin-related myopathies
Author: Appleton, Marie
ISNI:       0000 0004 7965 5164
Awarding Body: Newcastle University
Current Institution: University of Newcastle upon Tyne
Date of Award: 2018
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
The statins, inhibitors of 3‐hydroxy‐3‐methylglutaryl‐CoA reductase, are the mainstay of the treatment of hypercholesterolaemia, atherosclerosis and coronary artery disease. However, some patients develop myopathy which may be related to pre‐disposing factors such as high cellular statin uptake, or effects on other, non‐sterol isoprenoids, such as CoQ10, prenylation and geranylgeranylation of proteins, dolichols, or due to alterations in the distribution of cholesterol precursors. Mitochondrial dysfunction has been associated with statin‐related myopathy and it is possible that this arises secondary to inhibition of CoQ10 biosynthesis. This project was designed to develop methods for the measurement of CoQ10, and to enable differentiation between cholesterol precursors specific to the Bloch or Kandutsch‐Russell pathways. Tandem mass spectrometry was used to develop the CoQ10 assay and gas chromatograthy mass spectrometry was used for the quantitation of cholesterol and the sterol intermediates. These methods were then used to compare results from a large cohort of patients to test the hypothesis that modulated isoprenoid metabolism due to treatment with statins is involved in the aetiology of myopathy. To complement this the possible influence of statins in vitro was examined and showed decreased CoQ10 synthesis, together with evidence of increased mitochondrial superoxide production and an enhanced cellular mitochondrial mass. Despite this, using the parameters investigated in this study no definitive association to statin‐related myopathy could be found, suggesting this process is a complex one and further investigations are needed.
Supervisor: Not available Sponsor: NIHR
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.779822  DOI: Not available
Share: